The TM group showed signicant improvements in HbA1c levels and insulin sensitivity reflected in reductions in HOMA-IR. HbA1c is considered a surrogate endpoint for diabetes. IR is a central feature of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback